ANGLE PLC’s new approach to Cancer diagnostics with Parsortix - One2One Investor Forum

(32:20)

ANGLE plc (AGL) - Andrew Newland, CEO and Ian Griffiths, CFO

(37:18)

ANGLE, PLC., (OTCQX: ANPCY) (AIM: AGL)

(14:38)

ANGLE Parsortix Procedure

(6:31)

ANGLE PLC: Proactive One2One Virtual Conference

(32:41)

ANGLE, PLC., (OTCQX: ANPCY) (AIM: AGL)

(34:27)

ANGLE plc’s Parsortix a “game-changer” for prostate cancer detection, says CEO

(8:5)

ANGLE plc - How the Parsortix system works

(40)

ANGLE plc’s Parsortix a “game-changer” for prostate cancer detection, says CEO

(8:5)

ANGLE PLC submits its flagship Parsortix liquid biopsy diagnostic to the FDA

(7:27)

ANGLE PLC opens up potential route to market for Parsortix platform

(5:26)

ANGLE plc Presentation to Biotech Showcase Jan21

(30:47)

ANGLE plc's Parsortix device plays critical role in ground-breaking new cancer research

(9:8)

ANGLE PLC sees big opportunities in non-invasive prenatal testing

(9:29)

ANGLE PLC boss 'absolutely delighted' with results from pelvic mass study

(5:45)

ANGLE plc hails major breakthrough for Parsortix

(4:52)

ANGLE PLC presents at the Proactive One2One Investor Conference - January 11th

(32:30)

Oxford University Campus Tour

(11:37)

Products of Glaxo Smith kline | Business Empire Of glaxosmithkline | Brands \u0026 Products of GSK |

(1:44)

ANGLE PLC – a small British company changing the world in cancer

(23:24)

ANGLE plc Audio Interview 13 May 2013 Interim Results for the year ended 31 October 2013

(5:36)